Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 276Thoracic 65Gastrointestinal 52Dermatologic 37Breast 35Gynecologic 34Genitourinary 27Sarcoma 10Lymphoid 7Other solid neoplasm 3CNS 3Plasma cell 1Other hematologic neoplasm 1NET 1Endocrine 1Classical hematology 1

Conditions

Multiple Myeloma 432Lymphoma 54Recurrence 40Hematologic Neoplasms 35Neoplasms, Plasma Cell 34Immunoglobulin Light-chain Amyloidosis 31Smoldering Multiple Myeloma 28Lymphoma, Non-Hodgkin 24Leukemia, Myeloid, Acute 21Leukemia, Lymphocytic, Chronic, B-Cell 20Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Myelodysplastic Syndromes 16Hodgkin Disease 16Monoclonal Gammopathy of Undetermined Significance 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia 11Breast Neoplasms 11Waldenstrom Macroglobulinemia 10Prostatic Neoplasms 10Lymphoma, Mantle-Cell 10Paraproteinemias 9Ovarian Neoplasms 9Amyloidosis 9Lymphoma, Large B-Cell, Diffuse 8Lung Neoplasms 8Leukemia, Plasma Cell 8Melanoma 7Lymphoma, B-Cell 7Hematologic Diseases 7

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Plasma cell × 90 days × Clear all
NCT04354246 2026-05-12

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Compugen Ltd

Phase 1 Completed
94 enrolled
GastrointestinalGynecologicHead & NeckPlasma cellThoracic

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Lung Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡